Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
7(38.9%)
Phase 2
7(38.9%)
Phase 3
2(11.1%)
Phase 4
2(11.1%)
18Total
N/A(7)
Phase 2(7)
Phase 3(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT02743832Not ApplicableRecruiting

A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.

Role: collaborator

NCT07376681Enrolling By Invitation

Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Role: collaborator

NCT06756009Recruiting

Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters

Role: collaborator

NCT06092957Phase 3Recruiting

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Role: collaborator

NCT05986383Unknown

Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree

Role: collaborator

NCT04674345Phase 2Unknown

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Role: collaborator

NCT05008471Not ApplicableUnknown

Application of Whole-course Standardized Nutrition Management During Peri-radiotherapy in Patients With Nasopharyngeal Carcinoma After Radiotherapy: a Multicenter Randomized Controlled Clinical Study

Role: collaborator

NCT03620955Unknown

Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML

Role: collaborator

NCT03733834Unknown

SD vs. NSD Therapy in Elderly AML

Role: collaborator

NCT03665480Phase 2Unknown

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Role: collaborator

NCT03701217Phase 2Unknown

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Role: collaborator

NCT03221608Phase 3Unknown

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Role: collaborator

NCT03190733Phase 4Unknown

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Role: collaborator

NCT03081351Not ApplicableUnknown

Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy

Role: collaborator

NCT02886104Not ApplicableRecruiting

Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis

Role: collaborator

NCT02499718Not ApplicableUnknown

Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT02423278Phase 2Unknown

The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer

Role: collaborator

NCT01697410Not ApplicableUnknown

Continuos Terlipressin Infusion in Septic Shock

Role: collaborator

NCT02247973Phase 2Unknown

Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.

Role: collaborator

NCT02240225Unknown

Validation of Chinese SRI Questionnaire

Role: collaborator